louisiana glp-1 gi obstruction class action Ozempic Lawsuit [2026 Update] louisiana semaglutide gastric intestinal obstruction
Description
Get the most from these pricey new obesity drugs by choosing the right coverage strategy and helping your members build lifelong habits.
![louisiana glp-1 gi obstruction class action Ozempic Lawsuit [2026 Update] louisiana semaglutide gastric intestinal obstruction](https://lundyllp.com/wp-content/uploads/2023/12/Ozempic-Wegovy-Mounjary-gastrointestinal-injuries-claims-Louisiana-Lundy-LLP-400x250.jpg)
Tesamorelin 10mg 99.0% HPLC-verified research peptide
![louisiana glp-1 gi obstruction class action Ozempic Lawsuit [2026 Update] louisiana semaglutide gastric intestinal obstruction](https://ars.els-cdn.com/content/image/1-s2.0-S147968052500018X-JOE-24-0231fig1.jpg)
Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.
All it takes is the a few injections to hit your goal weight